Diana Campillo-Davo

5PUBLICATIONS
21CO-AUTHORS
NanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 04, 2026
Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine Modification.

|Mar 15, 2022
Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells.

Gils Roex, Diana Campillo-Davo, Donovan Flumens

|Sep 28, 2021
Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia.

Diana Campillo-Davo, Sébastien Anguille, Eva Lion

|Jun 13, 2020
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity.

Diede van Ens, Charlotte M Mousset, Tim J A Hutten

|Apr 09, 2020
Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment.

Á Rodríguez Pérez, D Campillo-Davo, V F I Van Tendeloo

Pageof 1

Frequent Collaborators

4 joint publications

Eva Lion

2 joint publications

Sébastien Anguille

1 joint publications

Á Rodríguez Pérez

1 joint publications

V F I Van Tendeloo